From: PET/CT vs CECT in assessment of therapeutic response in lymphoma
Number
Percent
Type
HL
12
60.0
NHL
8
40.0
Subtype
Anaplastic
1
5.0
B cell
5
25.0
Large B cell
7
35.0
Mixed cellular
3
15.0
NLPHL
Nodular sclerosis